{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:41:50Z","timestamp":1792590110823,"version":"4.5.0"},"reference-count":34,"publisher":"MyJove Corporation","issue":"230","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69843","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:00:48Z","timestamp":1776294048000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrative Analysis of Targeted Genomic Profiling and Immune Cell Infiltration in the Prognosis of Lung Adenocarcinoma"],"prefix":"10.3791","author":[{"given":"Xuechun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"ref1","first-page":"56","type":"journal-article","article-title":"Lung cancer: diagnosis and management","volume":"75","author":"Collins","year":"2007","unstructured":"Collins, L. G., Haines, C., Perkel, R. Enck, R. E. Lung cancer: diagnosis and management. Am Fam Physician. 75 (1), 56-63 (2007).","journal-title":"Am Fam Physician"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","type":"journal-article","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","unstructured":"Fridman, W. H., Zitvogel, L., Saut\u00e8s\u2013Fridman, C., Kroemer, G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 14 (12), 717-734 (2017).","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","type":"journal-article","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","unstructured":"Fridman, W. H., Pag\u00e8s, F., Saut\u00e8s-Fridman, C., Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 12 (4), 298-306 (2012).","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/02648725.2010.10648148","type":"journal-article","article-title":"Targeted deep resequencing of the human cancer genome using next-generation technologies","volume":"27","author":"Myllykangas","year":"2010","unstructured":"Myllykangas, S., Ji, H. P. Targeted deep resequencing of the human cancer genome using next-generation technologies. Biotechnol Genet Eng Rev. 27 (1), 135-158 (2010).","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","type":"journal-article","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Martinez-Jimenez","year":"2020","unstructured":"Martinez-Jimenez, F. et al. A compendium of mutational cancer driver genes. Nat Rev Cancer. 20 (10), 555-572 (2020).","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","type":"journal-article","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","unstructured":"Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Meth. 11 (4), 417-422 (2014).","journal-title":"Nat Meth"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2014.08.016","type":"journal-article","article-title":"Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis","volume":"70","author":"Stack","year":"2014","unstructured":"Stack, E. C., Wang, C., Roman, K. A., Hoyt, C. C. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 70 (1), 46-58 (2014).","journal-title":"Methods"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00262-018-2150-z","type":"journal-article","article-title":"Quantifying tumor-infiltrating immune cells from transcriptomics data","volume":"67","author":"Finotello","year":"2018","unstructured":"Finotello, F., Trajanoski, Z. Quantifying tumor-infiltrating immune cells from transcriptomics data. Cancer Immunol Immunother. 67 (7), 1031-1040 (2018).","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"ref9","first-page":"36","type":"journal-article","article-title":"Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques in the Lung Cancer Immunotherapy","volume":"24","author":"Sun","year":"2021","unstructured":"Sun, W., Zhou, J., Zhou, J. Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques in the Lung Cancer Immunotherapy. Zhongguo Fei Ai Za Zhi. 24 (1), 36-42 (2021).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jmoldx.2011.01.006","type":"journal-article","article-title":"Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue","volume":"13","author":"Duncavage","year":"2011","unstructured":"Duncavage, E. J. et al. Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. J Mol Diagnos. 13 (3), 325-333 (2011).","journal-title":"J Mol Diagnos"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","type":"journal-article","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","unstructured":"Li, M. M. et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 19 (1), 4-23 (2017).","journal-title":"J Mol Diagn"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","type":"journal-article","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17 (5), 405-424 (2015).","journal-title":"Genet Med"},{"key":"ref13","first-page":"467","type":"journal-article","article-title":"Multiplex immunofluorescence assays","author":"Francisco-Cruz","year":"2019","unstructured":"Francisco-Cruz, A., Parra, E. R., Tetzlaff, M. T., Wistuba, I. I. Multiplex immunofluorescence assays. Biomark Immunother Cancer Meth Protoc. 467-495 (2019).","journal-title":"Biomark Immunother Cancer Meth Protoc"},{"key":"ref14","type":"book","volume-title":"AJCC cancer staging manual","author":"Amin","year":"2017","unstructured":"Amin, M. B. et al. AJCC cancer staging manual. Springer. 1024 (2017)."},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1470-2045(09)70110-X","type":"journal-article","article-title":"EGFR testing in lung cancer is ready for prime time","volume":"10","author":"Hirsch","year":"2009","unstructured":"Hirsch, F. R., Bunn, P. A. EGFR testing in lung cancer is ready for prime time. Lancet Oncol. 10 (5), 432-433 (2009).","journal-title":"Lancet Oncol"},{"issue":"33","key":"ref16","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1200\/JCO.2007.12.6953","type":"journal-article","article-title":"Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer","volume":"25","author":"Tsao","year":"2007","unstructured":"Tsao, M. S. et al. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer. J Clin Oncol. 25 (33), 5240-5247 (2007).","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref17","first-page":"2892","type":"journal-article","article-title":"EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)","volume":"5","author":"Midha","year":"2015","unstructured":"Midha, A., Dearden, S., McCormack, R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res. 5 (9), 2892-2911 (2015).","journal-title":"Am J Cancer Res"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.prp.2017.09.008","type":"journal-article","article-title":"The relationship between EGFR mutation status and clinic-pathologic features in pulmonary adenocarcinoma","volume":"214","author":"Deng","year":"2018","unstructured":"Deng, H., Liu, J., Duan, X., Liu, Y. The relationship between EGFR mutation status and clinic-pathologic features in pulmonary adenocarcinoma. Pathol Res Pract. 214 (3), 450-454 (2018).","journal-title":"Pathol Res Pract"},{"key":"ref19","first-page":"59","type":"journal-article","article-title":"Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations","volume":"11","author":"Yang","year":"2020","unstructured":"Yang, W. et al. Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations. Lung Cancer (Auckl). 11, 59-71 (2020).","journal-title":"Lung Cancer (Auckl)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"644895","DOI":"10.3389\/fonc.2021.644895","type":"journal-article","article-title":"Unique Profile of Driver Gene Mutations in Patients With Non-Small-Cell Lung Cancer in Qujing City, Yunnan Province, Southwest China","volume":"11","author":"Zhou","year":"2021","unstructured":"Zhou, Y. et al. Unique Profile of Driver Gene Mutations in Patients With Non-Small-Cell Lung Cancer in Qujing City, Yunnan Province, Southwest China. Front Oncol. 11, 644895 (2021).","journal-title":"Front Oncol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.immuni.2018.09.020","type":"journal-article","article-title":"The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment","volume":"49","author":"Mollaoglu","year":"2018","unstructured":"Mollaoglu, G. et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 49 (4), 764-779 e769 (2018).","journal-title":"Immunity"},{"issue":"7749","key":"ref22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","type":"journal-article","article-title":"Neoantigen-directed immune escape in lung cancer evolution","volume":"567","author":"Rosenthal","year":"2019","unstructured":"Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature. 567 (7749), 479-485 (2019).","journal-title":"Nature"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neo.2019.01.005","type":"journal-article","article-title":"Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry","volume":"21","author":"Rakaee","year":"2019","unstructured":"Rakaee, M. et al. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Neoplasia. 21 (3), 282-293 (2019).","journal-title":"Neoplasia"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12967-020-02618-z","type":"journal-article","article-title":"Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients","volume":"18","author":"Hwang","year":"2020","unstructured":"Hwang, I. et al. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. J Transl Med. 18 (1), 443 (2020).","journal-title":"J Transl Med"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/ol.2023.13717","type":"journal-article","article-title":"Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC","volume":"25","author":"Ying","year":"2023","unstructured":"Ying, H. et al. Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC. Oncol Lett. 25 (3), 131 (2023).","journal-title":"Oncol Lett"},{"issue":"3","key":"ref26","first-page":"204","type":"journal-article","article-title":"Correlation between immune microenvironment features and EGFR mutation status in lung adenocarcinoma","volume":"26","author":"Hongyu","year":"2023","unstructured":"Hongyu, Z. et al. Correlation between immune microenvironment features and EGFR mutation status in lung adenocarcinoma. Chinese J Lung Cancer. 26 (3), 204 (2023).","journal-title":"Chinese J Lung Cancer"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.bjc.6604256","type":"journal-article","article-title":"High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer","volume":"98","author":"Kim","year":"2008","unstructured":"Kim, D. et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer. 98 (6), 1118-1124 (2008).","journal-title":"Br J Cancer"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3892\/mco.2023.2634","type":"journal-article","article-title":"Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor-infiltrating CD68-positive cell counts in patients with EGFR-mutant non-small cell lung cancer","volume":"18","author":"Tsuda","year":"2023","unstructured":"Tsuda, T. et al. Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor\u2011infiltrating CD68\u2011positive cell counts in patients with EGFR\u2011mutant non\u2011small cell lung cancer. Mol Clin Oncol. 18 (5), 38 (2023).","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"ref29","first-page":"136","type":"journal-article","article-title":"Systematic investigation of tumor microenvironment and antitumor immunity with IOBR","volume":"1","author":"Fang","year":"2025","unstructured":"Fang, Y. et al. Systematic investigation of tumor microenvironment and antitumor immunity with IOBR. Med Res. 1 (1), 136-140 (2025).","journal-title":"Med Res"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","type":"journal-article","article-title":"A novel methylation-based model for prognostic prediction in lung adenocarcinoma","volume":"25","author":"Li","year":"2024","unstructured":"Li, M. et al. A novel methylation-based model for prognostic prediction in lung adenocarcinoma. Curr Genom. 25 (1), 26-40 (2024).","journal-title":"Curr Genom"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"1325262","DOI":"10.1155\/sci\/1325262","type":"journal-article","article-title":"Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques","volume":"2025","author":"Wang","year":"2025","unstructured":"Wang, P., Xu, S., Guo, Q., Zhao, Y. Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques. Stem Cells Int. 2025 (1), 1325262 (2025).","journal-title":"Stem Cells Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"0723","DOI":"10.34133\/research.0723","type":"journal-article","article-title":"Natural killer cell immune checkpoints and their therapeutic targeting in cancer treatment","volume":"8","author":"Lin","year":"2025","unstructured":"Lin, A. et al. Natural killer cell immune checkpoints and their therapeutic targeting in cancer treatment. Research. 8, 0723 (2025).","journal-title":"Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1678907","DOI":"10.3389\/fimmu.2025.1678907","type":"journal-article","article-title":"Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies","volume":"16","author":"Wang","year":"2025","unstructured":"Wang, Y. et al. Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. Front Immunol. 16, 1678907 (2025).","journal-title":"Front Immunol"},{"issue":"1","key":"ref34","first-page":"62","type":"journal-article","article-title":"Breaking boundaries: chronic diseases and the frontiers of immune microenvironments","volume":"1","author":"Li","year":"2025","unstructured":"Li, G. et al. Breaking boundaries: chronic diseases and the frontiers of immune microenvironments. Med Res. 1 (1), 62-102 (2025).","journal-title":"Med Res"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69843\/integrative-analysis-targeted-genomic-profiling-immune-cell","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:00:14Z","timestamp":1792587614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69843\/integrative-analysis-targeted-genomic-profiling-immune-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":34,"journal-issue":{"issue":"230","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/69843","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}